Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

FDA & EMA

FDA Approves Tecentriq–Zepzelca Combo as First-Line Maintenance Therapy for ES-SC Lung Cancer

ONCOLife

The VAPOR 2 Trial and the Potential of Water Vapor Ablation in Prostate Cancer Treatment

FDA & EMA

DESTINY-Breast05: Enhertu Outperforms T-DM1 in High-Risk HER2+ Early Breast Cancer

ONCOLife

Dr. Eleni Lagkadinou Discusses How AbbVie Is Advancing Targeted Innovation for HT Cancers

FDA & EMA

FDA Approves Imlunestrant for ESR1-Mutated Metastatic Breast Cancer

ONCOLife

Sugary Drinks Drive Colorectal Cancer Metastasis via SORD Pathway, Study Finds

ONCOLife

SUNMO Trial: A New Chapter for Transplant-Ineligible Large B-Cell Lymphoma

ONCOLife

The V Foundation and CVC Collaborate to Advance Breast Cancer Vaccine Research

ONCOLife

Ferroptosis as a New Strategy: Iron-Driven Cell Death Targets Cancer Stem Cells

ONCOLife

Bacteria Cloak Viruses to Safely Deliver Cancer-Killing Payloads into Solid Tumors

ONCOLife Issues

Featured Articles

Datroway Improves Survival in First-Line Treatment of Metastatic Triple-Negative Breast Cancer

6 October 2025

The Phase III TROPION-Breast02 trial demonstrated that datopotamab deruxtecan (Datroway) achieved a statistically significant and clinically meaningful improvement in both overall and progression-free survival compared with chemotherapy in patients with metast...

Trending Articles

FDA Approves Papzimeos, First Immunotherapy for Recurrent Respiratory Papillomatosis

Breaking the Molecular Link Between Alcohol and Pancreatic Cancer by Targeting CREB

Clinical Trials

13 August 2025

PADCEV–KEYTRUDA Combination Delivers Survival Gains in High-Risk Bladder Cancer

ONCOLife

12 August 2025

FDA Grants Fast Track Designation to Birelentinib for Relapsed/Refractory CLL and SLL

FDA & EMA

9 August 2025

Genetic Testing Boosts Safety, Reduces Chemotherapy Side Effects in GI Cancer

ONCOLife

9 August 2025

Epcoritamab + R2 Achieves 95.7% ORR, Cuts Risk by 79% in R/R Follicular Lymphoma

Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR

FDA & EMA

8 August 2025

Novel Viral Immunotherapy SuperNova Gains FDA Fast Track Designation for Sarcoma

FDA & EMA

4 August 2025

FDA Fast-Tracks Breyanzi as First CAR T Cell Therapy for Marginal Zone Lymphoma

FDA & EMA

5 August 2025

FDA Approves Modeyso as First-Ever Therapy for Pediatric Brain Tumor, H3 K27M+ Glioma

FDA & EMA

6 August 2025

New Study Uncovers Hidden Disease in 42% of Ovarian Cancer Patients in Remission

2025 Pan-Mass Challenge Draws Thousands of Cyclists to Fuel Next Era of Cancer Research

ONCOLife

3 August 2025

Targeting eIF2A to Halt Melanoma: Study Reveals Key Driver of Cancer Cell Migration

ONCOLife

2 August 2025

New Radioimmunotherapy Strategy Eradicates Cancer Stem Cells in Ovarian Cancer

ONCOLife

1 August 2025

Dr. Iris Kuss: ARANOTE Trial Results Signal a New Era in Prostate Cancer Treatment

ONCOLife

1 August 2025